View the public protocol
Pfizer Inc, Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, HealthPartners Institute, Humana HealthCare Research. A Post-Authorization Safety Study to Evaluate the Safety of Abrocitinib Exposure During Pregnancy in United States Healthcare Databases (EUPAS1000000096). Amsterdam: European Medicines Agency (EMA); 2024 Apr 4. Available from: https://catalogues.ema.europa.eu/node/3997/administrative-details
